PAR 41.5% 46.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm PPS a potential in the treatment of viral arthritis-PAR.AX, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 348 Posts.
    lightbulb Created with Sketch. 40
    This is a massive multi billion dollar industry. If this drug works and is on shelves with sales generating an income stream. The share price will sky rocket in my opinion. Also what I like about this stock is that there is not many shares out there with this market cap. Therefore if successful. The share value of each share would be worth a lot more in value. This can already be seen with not many people keen to sell in my honest opinion. As everybody awaits for phase 2 trials to commence in December. Exciting times ahead.
    Good Luck to all who hold and invest.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.135(41.5%)
Mkt cap ! $82.30M
Open High Low Value Volume
34.0¢ 49.5¢ 34.0¢ $3.506M 8.474M

Buyers (Bids)

No. Vol. Price($)
1 10000 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 147167 1
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.